Chen Chunyang, Lu Ting, Wu Zhongshi, Xie Xinlong, Liu Yalin, Huang Can, Liu Yuhong
Department of Cardiovascular surgery, Second Xiangya Hospital of Central South University, Changsha, China.
Engineering Laboratory of Hunan Province for Cardiovascular Biomaterials, Changsha, China.
Front Bioeng Biotechnol. 2022 Aug 30;10:894956. doi: 10.3389/fbioe.2022.894956. eCollection 2022.
Neointima formation contributes to vascular grafts stenosis and thrombosis. It is a complex reaction that plays a significant role in the performance of vascular grafts. Despite its critical implications, little is known about the mechanisms underlying neointima formation. This study compares neointima proteome in different stages and plasma samples. Heterogenous acellular native arteries were implanted as abdominal aortic interposition grafts in a rabbit model. Grafts were harvested at 0.5, 1, 4, 6, 7, 14, 21, and 28 days post-surgery for histological and proteomic analysis of the neointima. Histological examination showed a transformed morphological pattern and components, including serum proteins, inflammatory cells, and regenerative cells. Proteomics analysis of the neointima showed distinct characteristics after 14 days of implantation compared to early implantation. Early changes in the neointima samples were proteins involved in acute inflammation and thrombosis, followed by the accumulation of extracellular matrix (ECM) proteins. A total of 110 proteins were found to be differentially expressed in later samples of neointima compared to early controls. The enriched pathways were mainly protein digestion and adsorption, focal adhesion, PI3K-Akt signaling pathway, and ECM-receptor interaction in the late stage. All distributions of proteins in the neointima are different compared to plasma. The biological processes of neointima formation at different stages identified with proteome found developmental characteristics of vascular structure on a decellularized small vascular graft, and significant differences were identified by proteomics in the neointima of early-stage and late-stage after implantation. In the acute unstable phase, the loose and uniform neointima was mainly composed of plasma proteins and inflammatory cells. However, in the relatively stable later stage, the most notable results were an up-regulation of ECM components. The present study demonstrates an interaction between biological matter and vascular graft, provides insights into biological process changes of neointima and facilitates the construction of a functional bioengineered small vascular graft for future clinical applications.
新生内膜形成会导致血管移植物狭窄和血栓形成。这是一种复杂的反应,在血管移植物的性能中起着重要作用。尽管其具有关键意义,但关于新生内膜形成的潜在机制却知之甚少。本研究比较了不同阶段新生内膜的蛋白质组和血浆样本。将异种脱细胞天然动脉作为腹主动脉置换移植物植入兔模型中。在术后0.5、1、4、6、7、14、21和28天采集移植物,用于新生内膜的组织学和蛋白质组分析。组织学检查显示形态模式和成分发生了改变,包括血清蛋白、炎性细胞和再生细胞。新生内膜的蛋白质组学分析显示,与早期植入相比,植入14天后具有明显特征。新生内膜样本的早期变化是参与急性炎症和血栓形成的蛋白质,随后是细胞外基质(ECM)蛋白的积累。与早期对照相比,共发现110种蛋白质在新生内膜后期样本中差异表达。后期富集的途径主要是蛋白质消化和吸收、粘着斑、PI3K-Akt信号通路和ECM-受体相互作用。新生内膜中所有蛋白质的分布与血浆不同。通过蛋白质组学鉴定的不同阶段新生内膜形成的生物学过程发现了去细胞化小血管移植物上血管结构的发育特征,并且通过蛋白质组学鉴定出植入后早期和晚期新生内膜存在显著差异。在急性不稳定期,疏松且均匀的新生内膜主要由血浆蛋白和炎性细胞组成。然而,在相对稳定的后期,最显著的结果是ECM成分上调。本研究证明了生物物质与血管移植物之间的相互作用,深入了解了新生内膜的生物学过程变化,并有助于构建功能性生物工程小血管移植物以供未来临床应用。